In patients with tumor-cell PD-L1 < 1%, median OS was comparable between NIVO + IPI and Chemo (14.5 vs. 14.2 months; HR 1.01 [0.66–1.54]) (Online Resource 3). The gene discussed is CD274; the disease is neoplasm.